Combined administration of anti ‐IL‐13 and anti‐IL‐17A at individually sub‐therapeutic doses limits asthma‐like symptoms in a mouse model of Th2/Th17 high asthma

Clinical&Experimental Allergy,Volume 0, Issue ja, -Not available-.

Source: Clinical and Experimental Allergy - October 24, 2018 Category: Allergy & Immunology Authors: Dasom Kim, Jaclyn W. McAlees, Lindsay J. Bischoff, Davinder Kaur, Lauren K. Houshel, Jerilyn Gray, Julie Hargis, Xenia Davis, Paul L. Dudas, Hitesh Deshmukh, Ian P. Lewkowich Source Type: research